Literature DB >> 21318613

Combination antibiotic treatment of severe community-acquired pneumonia.

Janet R Maurer1.   

Abstract

Entities:  

Year:  2011        PMID： 21318613     DOI： 10.1007/s11908-011-0170-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  6 in total

1.  Macrolide immunomodulation of chronic respiratory diseases.

Authors:  Daniel P Healy
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones.

Authors:  Mark L Metersky; Allen Ma; Peter M Houck; Dale W Bratzler
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

4.  Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock.

Authors:  Alejandro Rodríguez; Angel Mendia; Josep-María Sirvent; Fernando Barcenilla; María Victoria de la Torre-Prados; Jordi Solé-Violán; Jordi Rello
Journal:  Crit Care Med       Date:  2007-06       Impact factor: 7.598

5.  Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia.

Authors:  M I Restrepo; E M Mortensen; G W Waterer; R G Wunderink; J J Coalson; A Anzueto
Journal:  Eur Respir J       Date:  2008-09-03       Impact factor: 16.671

6.  Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.

Authors:  Larry M Baddour; Victor L Yu; Keith P Klugman; Charles Feldman; Ake Ortqvist; Jordi Rello; Arthur J Morris; Carlos M Luna; David R Snydman; Wen Chien Ko; M Bernadete F Chedid; David S Hui; Antoine Andremont; Christine C C Chiou
Journal:  Am J Respir Crit Care Med       Date:  2004-06-07       Impact factor: 21.405
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.